| Product name | ZNF592 Polyclonal Antibody |
| Immunogen | Synthesized peptide derived from the C-terminal region of human ZNF592 at AA range: 940-1020 |
| Host | Rabbit |
| Reactivity | Human,Mouse |
| Applications | WB,IHC,IF,ELISA |
| Applications notes | Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000;IHC 1:100-1:300;ELISA 1:40000;IF 1:50-200 |
| Clonality | Polyclonal |
| Preparation method | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Alternative | ZNF592; KIAA0211; Zinc finger protein 592 |
| Formulation | Liquid solution |
| Concentration | 1 mg/ml |
| Molecular weight | 160kD |
| Storage buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Storage instructions | Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing. |
| Shipping | Gel pack with blue ice. |
| Precautions | The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product. |
| Background | ZNF592 (zinc finger protein 592) is thought to play a role in a complex developmental pathway and the regulation of genes involved in cerebellar development. Mutations in ZNF592 have been associated with autosomal recessive spinocerebellar ataxia. |
| Gene ID | 9640 |
| Alternative | ZNF592; KIAA0211; Zinc finger protein 592 |
| Others | ZNF592 Polyclonal Antibody detects endogenous levels of ZNF592 protein. |
| Accession | Q92610 |
| Observed Band(KD) | 160 |
You must be logged in to post a review.
Reviews
There are no reviews yet.